Evidence map›Paper›PMID 34913996›Full record

ReviewApplied microbiology and biotechnology2022

Engineered nanomaterials in plant diseases: can we combat phytopathogens?

Graciela Dolores Avila-Quezada, Patrycja Golinska, Mahendra Rai

Erratum issuedOpen access · hybridAbstract readReview
PubMed Publisher
In one paragraph

Review in Applied microbiology and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Biosynthesized silver nanoparticles usingFrontiers in bioengineering and biotechnology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Graciela Dolores Avila-QuezadaFacultad de Ciencias Agrotecnológicas, Universidad Autónoma de Chihuahua, Escorza 900, Chihuahua, 31000, México.ORCID http://orcid.org/0000-0002-9633-152X
Patrycja GolinskaDepartment of Microbiology, Nicolaus Copernicus University, 87-100, Toruń, Poland.ORCID http://orcid.org/0000-0001-9154-8191
Mahendra RaiDepartment of Microbiology, Nicolaus Copernicus University, 87-100, Toruń, Poland. mahendrarai@sgbau.ac.in.ORCID http://orcid.org/0000-0003-0291-0422
Autonomous University of Chihuahua · MXNicolaus Copernicus University · PLSant Gadge Baba Amravati University · IN

Funding

Narodowa Agencja Wymiany Akademickiej PPN/ULM/2019/1/00117/A/DRAFT/00001
6 · The paper itself

Abstract

Engineered nanomaterials (ENM) have a high potential for use in several areas of agriculture including plant pathology. Nanoparticles (NPs) alone can be applied for disease management due to their antimicrobial properties. Moreover, nanobiosensors allow a rapid and sensitive diagnosis of pathogens because NPs can be conjugated with nucleic acids, proteins and other biomolecules. The use of ENM in diagnosis, delivery of fungicides and therapy is an eco-friendly and economically viable alternative. This review focuses on different promising studies concerning ENM used for plant disease management including viruses, fungi, oomycetes and bacteria; diagnosis and delivery of antimicrobials and factors affecting the efficacy of nanomaterials, entry, translocation and toxicity. Although much research is required on metallic NPs due to the possible risks to the final consumer, ENMs are undoubtedly very useful tools to achieve food security in the world. KEY POINTS: • Increasing global population and fungicides have necessitated alternative technologies. • Nanomaterials can be used for detection, delivery and therapy of plant diseases. • The toxicity issues and safety should be considered before the use of nanomaterials.

Indexed as

Metal NanoparticlesNanostructuresPlant PathologyAgriculturePlant DiseasesAntimicrobialsControlled releaseDisease detectionNanofungicidesToxicity

Identifiers

PMID34913996
OpenAlexW4200048644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.